Investigational drug · Phase 2
VNX001
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Interstitial Cystitis, Bladder Pain Syndrome.
Phase 2Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "VNX001"
First trial start
2023
May 22, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "VNX001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Interstitial Cystitis
- Bladder Pain Syndrome
Approved drugs for the same conditions: Rare and genetic disease · Kidney and urology · Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "VNX001" as an intervention, largest first.
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSPivotal-lookingRecruiting
Vaneltix Pharma, Inc.Industry
NCT05737121 · 120 participants (planned) · Start May 22, 2023 · Primary completion Jun 2026
Drug: VNX001; Placebo and 2 more · For: Interstitial Cystitis; Bladder Pain Syndrome
Sites: Escondido, California; Los Angeles, California; Newport Beach, California · 14 sites in all
Vaneltix Pharma, Inc.Industry
NCT06394830 · 50 participants (planned) · Start Dec 13, 2024 · Primary completion Jun 2026
Drug: VNX001 · For: Interstitial Cystitis; Bladder Pain Syndrome
Sites: Tucson, Arizona; Fresno, California; Tustin, California · 5 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.